FDA Inspection
KDC/ONE Development Corporation, Inc.KDC/ONE Development Corporation, Inc. – FDA Inspection, Sep 21, 2017
Record Details
This FDA Inspection record concerns KDC/ONE Development Corporation, Inc., with an inspection on September 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Emily J. Stoklosa (Issuing Officer)
View Company Profile
ID · ebdf1814-9cc4-484a-8cb9-ddbb5d2d193c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026564
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of KDC/ONE Development Corporation, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 31, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 12, 2009 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
Other documents for KDC/ONE Development Corporation, Inc.
- FDA Inspection 1195720 - 2023-01-27
- FDA Inspection 911255 - 2014-10-31
- FDA Inspection 829358 - 2012-12-06
- FDA Inspection 612357 - 2009-08-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.